Cargando…

Pharmacokinetic factors influencing risk assessment: saturation of biochemical processes and cofactor depletion.

Models generally consider risk to be a function of the hazard (toxicity) and exposure (dose). That function is best described by the dose response of the toxic effect. For any risk assessment system to be effective, it should consider that dose-response relationship. Saturation phenomena often produ...

Descripción completa

Detalles Bibliográficos
Autores principales: Sumner, D D, Stevens, J T
Formato: Texto
Lenguaje:English
Publicado: 1994
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1566761/
https://www.ncbi.nlm.nih.gov/pubmed/7737037
_version_ 1782129687100653568
author Sumner, D D
Stevens, J T
author_facet Sumner, D D
Stevens, J T
author_sort Sumner, D D
collection PubMed
description Models generally consider risk to be a function of the hazard (toxicity) and exposure (dose). That function is best described by the dose response of the toxic effect. For any risk assessment system to be effective, it should consider that dose-response relationship. Saturation phenomena often produce nonlinear dose curves, and any risk assessment system should be able to address such effects. Physiologically based pharmacokinetics offer an approach to deal with these nonlinear responses. Some historic risk models and common saturable processes are discussed. The impact of maximum tolerated dose (MTD) on risk evaluation and the kinetics of some saturable processes are considered. Specific examples have been selected to demonstrate the importance of saturation of processes in assessing the hazard of chemicals.
format Text
id pubmed-1566761
institution National Center for Biotechnology Information
language English
publishDate 1994
record_format MEDLINE/PubMed
spelling pubmed-15667612006-09-19 Pharmacokinetic factors influencing risk assessment: saturation of biochemical processes and cofactor depletion. Sumner, D D Stevens, J T Environ Health Perspect Research Article Models generally consider risk to be a function of the hazard (toxicity) and exposure (dose). That function is best described by the dose response of the toxic effect. For any risk assessment system to be effective, it should consider that dose-response relationship. Saturation phenomena often produce nonlinear dose curves, and any risk assessment system should be able to address such effects. Physiologically based pharmacokinetics offer an approach to deal with these nonlinear responses. Some historic risk models and common saturable processes are discussed. The impact of maximum tolerated dose (MTD) on risk evaluation and the kinetics of some saturable processes are considered. Specific examples have been selected to demonstrate the importance of saturation of processes in assessing the hazard of chemicals. 1994-12 /pmc/articles/PMC1566761/ /pubmed/7737037 Text en
spellingShingle Research Article
Sumner, D D
Stevens, J T
Pharmacokinetic factors influencing risk assessment: saturation of biochemical processes and cofactor depletion.
title Pharmacokinetic factors influencing risk assessment: saturation of biochemical processes and cofactor depletion.
title_full Pharmacokinetic factors influencing risk assessment: saturation of biochemical processes and cofactor depletion.
title_fullStr Pharmacokinetic factors influencing risk assessment: saturation of biochemical processes and cofactor depletion.
title_full_unstemmed Pharmacokinetic factors influencing risk assessment: saturation of biochemical processes and cofactor depletion.
title_short Pharmacokinetic factors influencing risk assessment: saturation of biochemical processes and cofactor depletion.
title_sort pharmacokinetic factors influencing risk assessment: saturation of biochemical processes and cofactor depletion.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1566761/
https://www.ncbi.nlm.nih.gov/pubmed/7737037
work_keys_str_mv AT sumnerdd pharmacokineticfactorsinfluencingriskassessmentsaturationofbiochemicalprocessesandcofactordepletion
AT stevensjt pharmacokineticfactorsinfluencingriskassessmentsaturationofbiochemicalprocessesandcofactordepletion